产房持续气道正压通气改善中低收入国家早产儿结局:系统评价与网状Meta分析
本研究通过系统评价与网状Meta分析,比较产房持续气道正压通气(DRCPAP)与氧疗、延迟DRCPAP、DRCPAP联合持续充气、DRCPAP联合肺表面活性物质及有创机械通气对中低收入国家早产儿结局的影响。共纳入18项研究,其中11项(4项观察性研究、7项RCT)共4210例早产儿的数据被合成。主要结局为接受有创机械通气:DRCPAP联合肺表面活性物质 vs 单纯DRCPAP无显著减少(RR 0.73,95%CrI 0.34–1.40,中等确定性证据);观察性研究中DRCPAP vs 氧疗显示减少有创机械通气的趋势(RR 0.75,95%CI 0.56–1.00,极低确定性证据)。网状Meta分析显示DRCPAP vs 氧疗有减少肺表面活性物质使用的趋势但未达统计学显著(RR 0.69,95%CrI 0.44–1.06,中等确定性证据)。与单纯氧疗或干预间比较,均未降低死亡率或支气管肺发育不良。
要点
- 中低收入国家早产儿中,DRCPAP联合肺表面活性物质 vs 单纯DRCPAP未显著减少后续有创机械通气(RR 0.73,95%CrI 0.34–1.40,中等确定性证据)。
- 观察性研究显示DRCPAP vs 氧疗有减少有创机械通气的趋势(RR 0.75,95%CI 0.56–1.00),但证据确定性极低。
- 网状Meta分析显示DRCPAP vs 氧疗有减少肺表面活性物质使用的趋势,但未达统计学显著(RR 0.69,95%CrI 0.44–1.06,中等确定性证据)。
- 网状Meta分析表明,与单纯氧疗或干预间相互比较,均未降低死亡率或支气管肺发育不良(中等确定性证据)。
- 作者认为现有证据不足以支持DRCPAP的使用,但也未显示 harm;建议未来研究评估中低收入国家改善DRCPAP效果的其他障碍。
适用人群与场景
- 中低收入国家的早产儿。
研究设计与关键结果
- 系统评价与网状Meta分析,纳入观察性研究和随机对照试验(RCT),检索Medline、Embase、CENTRAL、WOS和CINAHL。
- 共纳入18项研究,其中11项(4项观察性研究、7项RCT)共4210例早产儿的数据被合成。
- 主要结局为接受有创机械通气:DRCPAP联合肺表面活性物质 vs 单纯DRCPAP未显著减少(RR 0.73,95%CrI 0.34–1.40,中等确定性证据)。
- 观察性研究中DRCPAP vs 氧疗显示减少有创机械通气的趋势(RR 0.75,95%CI 0.56–1.00,极低确定性证据)。
- 网状Meta分析显示DRCPAP vs 氧疗有减少肺表面活性物质使用的趋势但未达统计学显著(RR 0.69,95%CrI 0.44–1.06,中等确定性证据)。
- 网状Meta分析显示,与单纯氧疗或干预间相互比较,均未降低死亡率或支气管肺发育不良(中等确定性证据)。
证据类型、等级与局限
- 证据类型:系统评价与网状Meta分析(纳入观察性研究和RCT)。
- 证据确定性:主要结局的确定性极低;DRCPAP联合肺表面活性物质 vs 单纯DRCPAP减少有创机械通气的证据确定性为中等;DRCPAP vs 氧疗减少肺表面活性物质使用的证据确定性为中等;DRCPAP vs 氧疗减少有创机械通气的观察性证据确定性为极低。
- 局限:主要结局的证据确定性极低。
对床旁实践的改变
- 作者认为现有证据不足以支持DRCPAP的使用,但也未显示 harm。
- 作者建议未来研究评估中低收入国家改善DRCPAP效果的其他障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To study the impact of delivery room continuous positive airway pressure (DRCPAP) on outcomes of preterm neonates in low- and middle- income countries (LMICs) by comparing with interventions: oxygen supplementation, late DRCPAP, DRCPAP with sustained inflation, DRCPAP with surfactant and invasive mechanical ventilation (IMV).
METHODS: Medline, Embase, CENTRAL, WOS and CINAHL searched. Observational studies and randomized controlled trials (RCTs) were included. Pair-wise meta-analysis and Bayesian network meta-analysis (NMA) were utilized. Primary outcome was receipt of IMV.
RESULTS: Data from 11 of the 18 included studies (4 observational studies, 7 RCTs) enrolling 4210 preterm infants was synthesized. Moderate certainty of evidence (CoE) from NMA of RCTs comparing DRCPAP with surfactant administration versus DRCPAP alone suggested no decrease in subsequent receipt of IMV [Risk ratio (RR); 95% Credible Interval (CrI): 0.73; (0.34, 1.40)]. Very low CoE from observational studies comparing use of DRCPAP versus oxygen supplementation indicated a trend towards decreased IMV [RR; 95% Confidence Interval (CI): 0.75; (0.56-1.00)]. Although moderate CoE from NMA evaluating DRCPAP versus oxygen supplementation showed a trend towards decreased receipt of surfactant, it did not reach statistical significance [RR; 95% CrI: 0.69; (0.44, 1.06)]. Moderate CoE from NMA indicated that none of the interventions, when compared with use of supplemental oxygen alone or with each other decreased mortality or bronchopulmonary dysplasia.
LIMITATIONS: CoE was very low for primary outcome.
CONCLUSIONS: Present evidence is not sufficient for use of DRCPAP, but also did not show harm. Since it seems unlikely that there are marked variations in patient physiology to explain the difference in efficacy between high income countries and LMICs, we suggest future research evaluating other barriers in improving the effectiveness of DRCPAP in LMICs.
参考来源
- Ramaswamy VV, Abiramalatha T, Bandyopadhyay T, et al. Delivery room CPAP in improving outcomes of preterm neonates in low-and middle-income countries: A systematic review and network meta-analysis. Resuscitation. 2021. PMID: 34757058. doi:10.1016/j.resuscitation.2021.10.027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。